| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.005 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.34 | 0.07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |